Hims Stock Catapults After Inking Deal To Sell Novo Nordisk's Wegovy
In This Article:
Hims stock launched Tuesday after the company inked a deal to offer Novo Nordisk's weight-loss drug, Wegovy, on its telehealth platform.
Oops, something went wrong
Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Hims stock launched Tuesday after the company inked a deal to offer Novo Nordisk's weight-loss drug, Wegovy, on its telehealth platform.